Citations for
1KLK10, KLK13, KLK7, KLK9
Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.
Filippou PS, Ren AH, Soosaipillai A, Safar R, Prassas I, Diamandis EP, Conner JR.
Clin Biochem 77:41-47. doi: 10.1016/j.clinbiochem.2019.12.015. Epub 2020 Jan 2. 2020
2KLK10, KLK15, KLK2, KLK3, KLK6, KLK7, KLK8
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Tailor PD, Kodeboyina SK, Bai S, Patel N, Sharma S, Ratnani A, Copland JA, She JX, Sharma A.
Oncotarget 9(25):17876-17888. doi: 10.18632/oncotarget.24947. eCollection 2018 Apr 3. 2018
3KLK5, KLK7, SPINK5
Toll-like receptor signaling induces the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
Sugimoto S, Morizane S, Nomura H, Kobashi M, Sugihara S, Iwatsuki K.
J Dermatol Sci 92(2):181-187. doi: 10.1016/j.jdermsci.2018.09.001. Epub 2018 Sep 15. 2018
4KLK14, KLK5, KLK7, SERPINA12
Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin.
Ulbricht D, Tindall CA, Oertwig K, Hanke S, Sträter N, Heiker JT.
Biol Chem 399(9):1079-1084. doi: 10.1515/hsz-2018-0108. 2018
5KLK5, KLK7
KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype.
Kasparek P, Ileninova Z, Zbodakova O, Kanchev I, Benada O, Chalupsky K, Brattsand M, Beck IM, Sedlacek R.
PLoS Genet 13(1):e1006566. doi: 10.1371/journal.pgen.1006566. eCollection 2017 Jan. 2017
6KLK5, KLK7, PI3, SPINK5
Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
McGovern JA, Meinert C, de Veer SJ, Hollier BG, Parker TJ, Upton Z.
Br J Dermatol 176(1):145-158. doi: 10.1111/bjd.14879. Epub 2016 Dec 22. 2017
7KLK5, KLK6, KLK7, KLK8, KLK9
Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing.
Adamopoulos PG, Kontos CK, Scorilas A.
Sci Rep 7(1):17299. doi: 10.1038/s41598-017-16269-6. 2017
8KLK5, kLK7
Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
McGovern JA, Meinert C, de Veer SJ, Hollier BG, Parker TJ, Upton Z.
Br J Dermatol 176(1):145-158. doi: 10.1111/bjd.14879. Epub 2016 Dec 22. 2017
9KLK14, KLK5, KLK7
Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
de Veer SJ, Furio L, Swedberg JE, Munro CA, Brattsand M, Clements JA, Hovnanian A, Harris JM.
J Invest Dermatol 137(2):430-439. doi: 10.1016/j.jid.2016.09.017. Epub 2016 Sep 30. 2017
10KLK7
Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells.
Raju I, Kaushal GP, Haun RS.
Biol Chem 397(11):1135-1146. doi: 10.1515/hsz-2015-0307. 2016
11KLK6, KLK7, KLK9
Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Drucker KL, Gianinni C, Decker PA, Diamandis EP, Scarisbrick IA.
BMC Cancer 15:565. doi: 10.1186/s12885-015-1566-5. 2015
12KLK7
Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
Walker F, Nicole P, Jallane A, Soosaipillai A, Mosbach V, Oikonomopoulou K, Diamandis EP, Magdolen V, Darmoul D.
Biol Chem 395(9):1075-86. doi: 10.1515/hsz-2014-0142. 2014
13KLK7, SERPINA12
Vaspin inhibits kallikrein 7 by serpin mechanism.
Heiker JT, Klöting N, Kovacs P, Kuettner EB, Sträter N, Schultz S, Kern M, Stumvoll M, Blüher M, Beck-Sickinger AG.
Cell Mol Life Sci 70(14):2569-83. doi: 10.1007/s00018-013-1258-8. Epub 2013 Jan 31. 2013
14CMKLR1, KLK7
Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement.
Schultz S, Saalbach A, Heiker JT, Meier R, Zellmann T, Simon JC, Beck-Sickinger AG.
Biochem J 452(2):271-80. doi: 10.1042/BJ20121880. 2013
15KLK14, KLK7
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Devetzi M, Trangas T, Scorilas A, Xynopoulos D, Talieri M.
Thromb Haemost 109(4):716-25. doi: 10.1160/TH12-07-0518. Epub 2012 Dec 6. 2013
16CASP14, KLK7
Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form.
Yamamoto M, Miyai M, Matsumoto Y, Tsuboi R, Hibino T.
J Biol Chem 287(39):32825-34. Epub 2012 Jul 23. 2012
17KLK7
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.
Ramani VC, Kaushal GP, Haun RS.
Biochim Biophys Acta 1813(8):1525-31. doi: 10.1016/j.bbamcr.2011.05.007. Epub 2011 May 17. 2011
18KLK11, KLK7
Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.
Jamaspishvili T, Scorilas A, Kral M, Khomeriki I, Kurfurstova D, Kolar Z, Bouchal J.
Neoplasma 58(4):298-303. 2011
19KLK1, KLK15, KLK6, KLK7
Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
Gabril M, White NM, Moussa M, Chow TF, Metias SM, Fatoohi E, Yousef GM.
Biol Chem iol Chem. 2010 Feb 3. [Epub ahead of print]PMID: 20128686 2010
20KLK10, KLK5, KLK7, KLK8
Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.
Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S, Liu Y, Ravosa MJ, Frazier S, Stack MS.
Histol Histopathol 24(2):197-207. 2009
21KLK5, KLK7
Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
Li X, Liu J, Wang Y, Zhang L, Ning L, Feng Y.
Cancer Sci 100(4):601-7.PMID: 19453546 2009
22KLK7
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A, Arnogiannaki N, Scorilas A.
Thromb Haemost 101(4):741-7.PMID: 19350120 2009
23KLK7
The extracellular matrix protein fibronectin is a substrate for kallikrein 7.
Ramani VC, Haun RS.
Biochem Biophys Res Commun 369(4):1169-73. Epub 2008 Mar 14. 2008
24KLK4, KLK5, KLK6, KLK7
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
Debela M, Beaufort N, Magdolen V, Schechter NM, Craik CS, Schmitt M, Bode W, Goettig P.
Biol Chem 389(6):623-32. Review.PMID: 18627343 2008
25KLK7, SLPI
Expression of the serine protease kallikrein 7 and its inhibitor antileukoprotease is decreased in prostate cancer.
Xuan Q, Yang X, Mo L, Huang F, Pang Y, Qin M, Chen Z, He M, Wang Q, Mo ZN.
Arch Pathol Lab Med 132(11):1796-801.PMID: 18976018 2008
26KLK13, KLK2, KLK3, KLK5, KLK6, KLK7, KLK8
Distribution of 15 human kallikreins in tissues and biological fluids.
Shaw JL, Diamandis EP.
Clin Chem 53(8):1423-32. Epub 2007 Jun 15.PMID: 17573418 2007
27KLK5, KLK7, KLK14
Kallikrein-related peptidase 14 may be a major contributor to trypsin-like proteolytic activity in human stratum corneum.
Stefansson K, Brattsand M, Ny A, Glas B, Egelrud T.
Biol Chem 387(6):761-8. 2006
28SPINK5, KLK5, KLK7
LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
Ishida-Yamamoto A, Deraison C, Bonnart C, Bitoun E, Robinson R, O'Brien TJ, Wakamatsu K, Ohtsubo S, Takahashi H, Hashimoto Y, Dopping-Hepenstal PJ, McGrath JA, Iizuka H, Richard G, Hovnanian A.
J Invest Dermatol 124(2):360-6. 2005
29KLK5, KLK7
KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.
Planque C, de Monte M, Guyetant S, Rollin J, Desmazes C, Panel V, Lemarie E, Courty Y.
Biochem Biophys Res Commun 329(4):1260-6. 2005
30KLK7
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.
Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A.
Thromb Haemost 91(1):180-6. 2004
31KLK7
Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA.
Clin Cancer Res 9(5):1710-20. 2003
32KLK10, KLK11, KLK12, KLK13, KLK14, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9
The New Human Kallikrein Gene Family: Implications in Carcinogenesis.
Diamandis EP, Yousef GM, Luo I, Magklara I, Obiezu CV.
Trends Endocrinol Metab 11(2):54-60. 2000
33KLK1, KLK10, KLK11, KLK12, KLK13, KLK2, KLK3, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4.
Harvey TJ, Hooper JD, Myers SA, Stephenson SA, Ashworth LK, Clements JA.
J Biol Chem 275(48):37397-406. 2000
34KLK7
Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase.
Hansson L, Stromqvist M, Backman A, Wallbrandt P, Carlstein A, Egelrud T.
J Biol Chem 269(30):19420-6. 1994